Videos and Webinars

Here, you can view a selection of REPROCELL's explainer videos and past webinars.

Stay up to date with the latest REPROCELL video content on the REPROCELL YouTube Channel.

Contents

REPROCELL Webinars

WEBINAR Innovative Technology to Bioengineer human tissue
Innovative Technology to Bioengineer human tissue
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Mature chamber specific human cardiomyocytes video cover
Mature Chamber Specific Human Cardiomyocytes for High Throughput Cardiotoxicity Testing
Anne E. Sheldrake, M.S.
StemBioSys
Todd J. Herron, Ph.D.
Frankel Cardiovascular Center, University of Michigan
Production of Mesenchymal Stem Cells (MSCs) for Clinical and Research Projects
Evelyn Chukwurah, Ph.D.
REPROCELL USA
Naiarah de Paz, M.Sc.
COO, Histocell
Working with Mature, Chamber-Specific Cardiomyocytes
Dr Travis Block
Chief Technology Officer, StemBioSys
Human Tissue in Drug Discovery Scientific, Technical & Regulatory Perspective
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Clinically compatible advances in blood-derived EPC isolation and reprogramming
Dr Amer Rana
Director of Biomedical Research Center, University of East Anglia, UK
Enabling translational research through access to high quality biospecimens
Dr. Rachna Goyal
Manager, Preclinical Genomics, REPROCELL USA
How to culture iPSCs in suspension without agitation
Masashi Iwakami
Nissan Chemical Corporation, Japan
What is human tissue testing?
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Improving precision medicine with human tissue testing and genomics
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Bioengineered Human Tissues for Skin, Cancer, and Drug Metabolism
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Dr. James Shoemaker
CSO, Lena Biosciences, USA
Review of current regulatory issues on ancillary materials and importance of animal origin free products
Dr. Takuya Matsumoto
Institute for BioScience at Ajinomoto Co. Inc. Japan
Providing testing solutions for the development of SARS-CoV-2 therapeutics
Prof. Anne Dickinson
Translational and Clinical Research Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, UK
Dr. Terri Lehman
Chief Technical Officer, REPROCELL Bioserve, USA
How Pharma is using fresh human tissues to better predict drug safety and efficacy
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
The development and application of advanced cell culture techniques to construct models of human tissues
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Novel Uses for PCR of iPSCs in Drug Discovery and Cell Biology
Dr. Tsukasa Sugo
CEO and Founder of GenAhead Bio in Fujisawa, Japan
The REPROCELL Biobank: A Unique Tool for Neurodegenerative Disease Research
Dr. Jean Phillipe Richard
Stem Cell Director, REPROCELL USA
The REPROCELL Tissue Network: Facilitating Dermatological Drug Development
Dr. Karen McAuley
Clinical Alliances Manager, REPROCELL Europe
Graeme Macluskie
Director of Precision Medicine, REPROCELL Europe

Animated Explainer Videos

Human Tissue Testing Videos

Note: Biopta (Glasgow, UK and Maryland, USA) is now REPROCELL’s Center for predictive Drug Discovery.

Alvetex Videos

Note: Reinnervate (Durham, UK) is now part of REPROCELL’s Center for predictive Drug Discovery.

Stem Cell Product Videos